Alexis Nolte

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The evaluation of quality, safety, and efficacy of medicinal products by the European Medicines Evaluation Agency (EMEA) via the centralized procedure is the only available regulatory procedure for obtaining marketing authorization for gene therapy (GT) medicinal products in the European Union. The responsibility for the authorization of clinical trials(More)
  • 1